Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country
Jayastu Senapati, Rishi Dhawan, Mukul Aggarwal, Pradeep Kumar, Ganesh Kumar Vishwanathan, Jasmita Dass, Seema Tyagi, Manoranjan Mahapatra, Tulika Seth
Abstract
Despite improvements in leukemia therapy, acute myeloid leukemia (AML) remain a difficult disease to treat with a majority of patients having disease relapse without an allogeneic stem cell transpl...
Topics & Concepts
VenetoclaxAzacitidinePerspective (graphical)MedicineOncologyInternal medicineLeukemiaBiologyChronic lymphocytic leukemiaComputer scienceGeneArtificial intelligenceBiochemistryDNA methylationGene expressionAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchHematopoietic Stem Cell Transplantation